Kathleen Wisemandle, MSLOC, DOEC 🌿

Seeking Biotech Pioneers! In the fast-paced world of biotechnology, the right team isn't just an asset; it's the heartbeat of innovation. As a seasoned professional in the Clinical Operations sector, I understand the unique challenges you face in staffing projects that push the boundaries of science and medicine. Are you tirelessly searching for that perfect fit to drive your clinical trials forward? Look no further. My expertise lies in providing bespoke contract staffing solutions tailored to the dynamic needs of biotech firms across Europe. I bridge the gap between visionary companies and the top-tier talent they need to thrive. Here's what I bring to your table: - A robust network of pre-vetted clinical operations professionals - Swift turnaround times to keep your projects on track - A deep understanding of the biotech landscape and regulatory requirements - Flexible staffing models to suit your project scale and duration Whether you're a start-up on the verge of a breakthrough or an established firm scaling new heights, my goal is to empower your mission with the right people behind the science. Let's collaborate to build a future where health innovations reach those who need them most, faster and more efficiently. Drop a comment, send a message, or simply hit 'Like' if you're ready to elevate your clinical operations with the top talent in the industry. #BiotechTalent #ClinicalOperations #StaffingSolutions #Science #HRS

8

In #NeurodegenerativeDisease news, specifically on an experimental treatment for #ALS, with this new #strategic partnership is penned between Dewpoint Therapeutics and Mitsubishi Tanabe Pharma America. ⚛️ The asset is the former's drug, designed "to address the accumulation of a protein into toxic structures that lead to neuronal dysfunction in people with ALS." 🤝 The alliance would grant MTP exclusive rights to license, upon achieving certain developmental milestones. ⚕️ This would add to MTP's existing US-marketed ALS treatment, #Radicava https://lnkd.in/evayrVv4' #Dewpoint #Mitsubishi #Pharma #Biopharma #Healthcare

6

The Q3 Job Market Report from BioSpace just dropped, and you definitely want to check it out! The life sciences job market is going through some big changes, and keeping up with the latest info is super important for navigating it all. According to the new BioSpace data, there are some challenges but also plenty of opportunities coming up! 🔍 Key Insights from BioSpace's Q3 2024 Report: 1. Decrease in Job Postings:   - There were 21,548 jobs live on BioSpace in Q3 2024.   - This is a 12% decrease from 24,503 jobs in Q3 2023. 2. Increase in Job Competition:   - The job response rate (percentage of people applying after viewing) jumped from 9.8% to 14.8%, a 51% increase year-over-year.   - Notably, from July to September 2024, the response rate surged from 14.5% to 18.4%, a 26.9% increase. 3. Top States for Job Openings:   - California: 3,769 jobs   - Massachusetts: 3,110 jobs   - New Jersey: 2,513 jobs   - Illinois: 2,452 jobs   - New York: 1,717 jobs 4. Impact of Layoffs:   - In Q3 2024, there were 54 rounds of layoffs in biotech and pharma, affecting at least 3,700 employees.   Significant layoffs included:    - FibroGen, Inc.: Let go of 75% of its U.S.-based workforce (~356 people).    - GRAIL: Laid off about 350 employees.    - BioMarin Pharmaceutical Inc.: Cut 225 positions globally.    - Johnson & Johnson & Bayer: Combined layoffs of 288 employees in New Jersey. 💡 What This Means for You: - Increased Competition: With fewer job postings and more professionals in the market, it's crucial to differentiate yourself. - Strategic Job Hunting: According to Carina Clingman, PhD, CEO of Recruitomics Consulting, fall is prime time for job hunting in biotech. Companies aim to fill positions before the budget cycle ends around Thanksgiving. 📈 Emerging Opportunities:  - Johnson & Johnson is investing $2 billion in a new biologics manufacturing plant in Wilson, North Carolina, expected to create 420 new full-time, highly skilled jobs. Construction begins in the first half of 2024.  - Eli Lilly and Company is committing $4.5 billion to build a facility in Lebanon, Indiana, housing research and manufacturing. Set to open in late 2027, it will employ about 400 new engineers, scientists, lab technicians, and operations personnel.  - MassBio's 5-Year Plan: Aiming to create hundreds of new biopharma and life sciences positions in Massachusetts by 2030, focusing on supporting early-stage biotech growth. 🚀 Tips to Stay Ahead: - Update Your Skills: Leverage this time to enhance your expertise and stay competitive. - Network: Engage with industry peers and attend virtual or in-person events. - Stay Informed: Keep an eye on emerging biotech hubs and companies expanding their workforce. - Be Proactive: Tailor your applications and highlight how you can add value in this dynamic environment. Share your experiences or tips below. #Biotech #Pharma #JobMarket #CareerGrowth #LifeSciences

4

🚀 Biotech Q3 Scorecard: 19 Stock-Moving Events to Watch! 📊 Exciting times ahead in the biotech world! Here are key developments to keep on your radar: Alnylam Pharmaceuticals vutrisiran vs BridgeBio acoramidis for ATTR-CM: ESC presentation in August Novo Nordisk's monlunabant for obesity: Phase 2 results (watch Skye Bioscience Inc. and Corbus, LLC too!) Viridian Therapeutics, Inc.'s VRDN-001 for thyroid eye disease: Phase 3 readout in September Sage Therapeutics' Sage-324 for essential tremor: Mid-stage study results Apellis Pharmaceuticals' Empaveli for kidney diseases: Phase 3 VALIANT study results early Q3 Eli Lilly and Company's bimagrumab for obesity: Phase 2 results mid-year UCB and Biogen's dapirolizumab for lupus: Phase 3 results Neurocrine Biosciences's NBI-1117568 for schizophrenia: Phase 2 results Elevation Oncology's EO-3021 for gastric/pancreatic cancers: Data update Plus: • AstraZeneca's Imfinzi FDA panel (July 25) • Potential approvals for Alzheimer's drugs: Eisai US/Biogen's Leqembi (EU) • Multiple FDA decisions including Gilead Sciences, Regeneron, Syndax Pharmaceuticals, Roche, and Bristol Myers Squibb 🔬 The biotech sector is buzzing with potential breakthroughs. Which company or development are you most excited about? Share your thoughts below! 👇 #Biotech #PharmaTrends #ClinicalTrials #DrugDevelopment

5

🔬 Biopharma Layoffs: Navigating Challenges in a Shifting Landscape Recent trends in biopharma layoffs have left many scientists reeling. Here are key takeaways from a recent STAT article: 67% of life science layoffs in H1 2024 were at large biopharma companies (>$1B annual sales), up from 47% in 2021-2023. Job postings in biotech dropped from 21,366 to 12,300 between early 2021 and 2024. Scientists face unique challenges in job searches, including maintaining confidentiality about previous work. Visa constraints add pressure for international workers, limiting job search time. Networking remains crucial: Some successful companies are hiring primarily through personal connections. The industry sees this as part of a cyclical pattern, influenced by patent expirations and acquisitions. Despite these challenges, opportunities still exist. Adaptability, networking, and a broader job search approach are key for scientists navigating this evolving landscape. What strategies have you found effective in weathering industry changes? Share your thoughts below! #BiopharmaJobs #CareerTransition #LifeSciences #Networking

3

The rise of the millennial C-suite 📊 This transformation in executive leadership brings fascinating implications for pharma and biotech: Modern executives are showing a remarkable evolution: - Only 59% have worked in a single job function (down from 87% in 2018) - Just 63% stayed at one company before reaching executive level (previously 89%) - 30% increase in emphasis on soft skills among C-suite leaders What does this mean for pharma/biotech professionals? - Career paths are becoming more dynamic - Cross-functional experience is increasingly valued - Soft skills are now as crucial as technical expertise - Leadership styles are evolving to be more adaptable For both hiring managers and candidates in life sciences, this signals the need for a fresh approach to career development and talent assessment. Traditional linear career paths are giving way to more diverse experiences. Curious to hear from my pharma/biotech network: How are you preparing for this leadership evolution? What skills beyond technical expertise are you prioritizing? #BiotechLeadership #PharmaceuticalIndustry #ExecutiveLeadership #CareerGrowth

3

The Biopharma Job Market in 2024: A Reality Check I feel compelled to address some misconceptions about the current job market. While some recruiters may be expressing optimism about hiring picking up or the market turning around, the data tells a different story. Let's look at the facts: Layoff Trends: Q2 2024 saw a significant increase in biopharma layoffs, with at least 7,616 workers impacted. This is more than triple the 2,398 layoffs reported in Q1 2024. Major Players Affected: Industry giants like Novartis, Indivior, CureVac, and Takeda have all announced substantial job cuts in recent months. Ongoing Restructuring: Many companies are still in the midst of restructuring efforts, with some planning layoffs that will continue into late 2024 and beyond. Biotech Volatility: While there are pockets of growth, particularly in well-funded startups, the overall biotech sector remains volatile. What This Means for Job Seekers: Be Cautious: Exercise caution when hearing overly optimistic projections from recruiters. Always verify claims with industry data. Stay Informed: Keep abreast of industry trends, company financials, and pipeline news to make informed decisions. Diversify Your Search: Consider roles in emerging biotech startups or adjacent industries that value pharma experience. Enhance Your Skills: Focus on developing skills that are in high demand, such as data analytics, digital health, or regulatory affairs. Network Strategically: Build relationships within the industry, not just for immediate opportunities but for long-term career growth. As recruiters, our role is to provide accurate, data-driven insights to both clients and candidates. While we all hope for market improvement, it's crucial to approach the current landscape with realism and strategic thinking. What strategies are you employing in this challenging market? Let's discuss in the comments. #PharmaceuticalIndustry #BiotechJobs #CareerAdvice #RecruitmentTrends

57

10 Comments

Thanks to Life Science Recruitment for publishing their recent Science Salary and Market trend report.

1

💥 Leveraging Real-World Evidence (RWE) in MSL Activities 💥 Don't miss this weeks MSL Talk Podcast with Elizabeth Pash, PhD, MS, RDN, Medical Affairs Executive Leader who shares insights on how to leverage real-world evidence (RWE) in MSL activities. This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery (dot) com. In this episode, Beth discusses… 👉 What is Real World Evidence and how it is different from Clinical Trial Data 👉 How MSLs can effectively incorporate RWE into their discussions with healthcare professionals and key opinion leaders (KOLs) 👉 Challenges MSLs typically face when presenting RWE to stakeholders, and how can they overcome them 👉 Ways RWE can be used to enhance the strategic value of MSL activities 👉 Key skills MSLs need to develop in order to effectively understand and communicate RWE to diverse audiences The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel. MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions. #msl #medicalaffairs #medicalscienceliaison #realworldevidence #careers

19

Are you navigating the complexities of Clinical Operations in the Biotech sphere? The right talent is the linchpin of success, especially in the highly specialized and dynamic field of Clinical Operations. As a seasoned professional with a deep understanding of the Biotech industry, I've witnessed the transformative impact that strategic staffing solutions can bring to companies like yours. I offer bespoke contract staffing services tailored to the unique needs of Biotech firms across Europe. With a robust network of pre-vetted professionals and a keen eye for the perfect candidate-to-role match, my mission is to empower your operations with the agility and expertise required to thrive in today's market. Whether you're scaling up for a pivotal trial or need niche expertise to navigate regulatory landscapes, my approach is not just about filling a vacancy. It's about understanding your company's DNA and finding individuals who will accelerate your journey from research to real-world solutions. Let's collaborate to ensure your Clinical Operations are powered by the industry's best talent, giving you the competitive edge necessary to lead in innovation and patient outcomes. Ready to elevate your Clinical Ops with top-tier European talent? Let's talk! #BiotechTalent #ClinicalOperations #StaffingSolutions #Science #HRS

6

💥 Time Audit: YOUR Strategy for Time Management Success 💥 Check out this weeks MSL Talk podcast with Patrina Pellett, PhD, MSL Excellence Lead at MSL Mastery and we discuss the benefits of conducting a time audit for maximizing your calendar. This weeks episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSL Mastery In this episode, we discuss….   👉 What is a time audit and how do I go about it 👉 Why is a time audit a good idea for time management success 👉 What are the challenges to be aware of when make calendar audits and adjustments 👉 How can one categorize their calendar items in a time audit and why is it important 👉 How does a time audit lead to better work life balance The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.     MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.   #msl #medicalaffairs #medicalscienceliaison #timemanagement #careers

16

7 Comments

💥 Top 5 MSL Frustrations and How to Overcome Them💥 The MSL Talk podcast is back after a 2 week long holiday break!! This weeks guests are Patrina Pellett, PhD, Medical Excellence Lead at MSL Mastery and Sarah Snyder, Medical Affairs Recruiter at The Carolan Group who discuss common frustrations faced by Medical Science Liaisons, exploring the top challenges and offering practical solutions. In this episode, we discuss… 👉 The top 5 most common MSL frustrations 👉 Practical ways to overcome field and personal challenges 👉 The importance of addressing self doubt and imposter syndrome This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery (dot) com. The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.   MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions. #msl #medicalaffairs #medicalscienceliaison #realworldevidence #careers

30

10 Comments

𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐑𝐎𝐔𝐍𝐃𝐔𝐏 ⚛️ The FDA has released new draft guidance recommending best practices for multi-regional clinical trials (MRCTs) in oncology. Sponsors are encouraged to ensure that the outcomes of global oncology clinical development programs are understandable for US patients in support of marketing applications. 🌐 The FDA's final guidance on decentralized clinical trials (DCTs) clarifies several concerns raised by clinical experts and industry stakeholders regarding the earlier draft. This includes detailed requirements for maintaining a task log for healthcare providers, guidelines for physical inspections, and addressing challenges related to data variability in DCTs. 🤖 As the use of artificial intelligence (AI) tools, particularly generative AI, expands, experts remind regulatory professionals to prioritize the human aspect. Although these tools offer significant benefits, they necessitate human oversight and interpretation to be fully effective. During the opening plenary session, experts discussed how AI can be utilized across various sectors, the potential of this technology, and the hurdles in achieving its full benefits. Panelists included Ryan Kurtzman from the City of Long Beach, Bradley Thompson of Epstein Becker Green, Michelle Jump from MedSec, and Jay Mashburn from Recursion Pharmaceuticals, with moderation by Megha Iyer of Thermo Fisher Scientific. 🧬 As biosimilars gain market presence, they are generating competition with original products. However, patient adoption of biosimilars varies based on demographics, location, care setting, prescriber specialties, and types of insurance, according to two recent studies in Health Affairs. 🌐 The FDA has observed a rise in complete response letters (CRLs) issued to sponsors of biologics license applications (BLAs) over the last decade, with facility deficiencies being the most common reason cited, according to Leslie Rivera Rosado, a supervisory interdisciplinary scientist at the agency's Center for Drug Evaluation and Research (CDER). #Pharmaceuticals #Biotechnology #LifeSciences #PharmaNews #Biotech #HealthcareInnovation #DrugDevelopment #ClinicalResearch #Biopharma #PharmaTech #MedicalResearch #Healthcare #BioPharmaceuticals #PharmaIndustry #BiotechIndustry #PharmaCareers #MedicalInnovation #NewDrugs #Genomics #BiotechNews

14

The article discusses Jupiter Bioventures recent $70 million fund aimed at supporting cancer biotechs, it shows a growing trend of investment in cancer therapies. This funding reflects a strong commitment to advancing cancer research and patient outcomes. #GxP #funding #oncology #Quality

6

📢 Biopharma Talent Movement This Week: Key Industry Shifts You Need to Know Here’s the roundup: 🚀 Leadership Shifts at Top-Tier Pharma Pfizer promoted Chris Boshoff, MD, PhD, FMedSci, to CSO and President, R&D, reinforcing its commitment to transformative R&D in oncology and rare diseases. Pfizer also hired Johanna Bendell as CDO, Oncology, leveraging her immuno-oncology expertise to strengthen clinical trials and pipeline. Amgen appointed Howard Chang as SVP, R&D, focusing on preclinical and discovery-stage programs. Johnson & Johnson named Chris Della Rocca as CIO, emphasizing the growing importance of tech-driven business operations. 🧬 Biotech CEO and Executive Appointments ExeVir named Michael Garrett as CEO to accelerate its antibody platform’s commercialization. Paragon Therapeutics, Inc. hired Susanna High as CEO, bringing a proven track record of scaling biotech startups. LFB brought in Karen PINACHYAN, MD as CMO, aligning clinical and regulatory strategies. ArrePath appointed Kevin Krause as CEO & President, with a focus on anti-infectives innovation. Metaphore Biotechnologies recruited Angela Hwang as CEO, marking her transition from Pfizer to lead a pioneering initiative. LB Pharmaceuticals, Inc. hired Heather Turner as CEO to drive forward psychiatric disorder programs. 💡 Key Commercial and Operational Moves IDEAYA Biosciences named Stu Dorman as CCO, preparing for product launches. Eikon Therapeutics added Michael Klobuchar as COO, a critical move as the company scales operations. 🔬 Specialized and Regulatory Hires MindMed hired Gregg Pratt as Chief Regulatory and QA Officer, crucial for navigating regulatory frameworks in psychedelic therapies. GeneDx and Vera Therapeutics, Inc. hired Heidi C Chen and Jason Carter as Chief Legal Officers to strengthen compliance. hims & hers appointed Janet Stevens as Global Head of Quality & Safety, signaling a strong focus on patient care and safety. 🌟 CFO Appointments Strengthen Financial Foundations NRx Pharmaceuticals, Inc. hired Michael Abramson as CFO, and Bluejay Therapeutics brought in Pete Garcia for the same role, likely in preparation for investment and partnership opportunities. 💼 Trends in Talent Strategy Focus on Oncology: Pfizer’s dual appointments and IDEAYA’s hire underscore oncology’s importance for innovation and resource allocation. Expansion of Quality and Regulatory Teams: Mind Medicine, Hims & Hers, and GeneDx’s hires reflect heightened scrutiny as pipelines mature. Leadership Churn in Startups: CEO appointments at ExeVir, Paragon, and Metaphore highlight the trend of startups bringing in seasoned leaders for commercialization. Companies are clearly prioritizing leadership with proven records of delivering scientific innovation and driving commercialization. Who will make the biggest impact? Let’s discuss in the comments below!

4

Let’s hope this is a big step forward by anticipating and addressing potential regulatory backlog given the inflection of #cellandgene therapy and #AI approaches. The logic being that a standardized framework for development platforms could take less assessment time and offer #biotech swifter approvals and reduced development costs. #innovation #medicine #pharmaceutical #

5

Looking forward to attending #ASH2024 this year. Let's connect and I can share with you how TD2 can support your next trial. 🔗https://hubs.li/Q02YXgqv0 #HematologyOncology #ClinicalTrials #OncologyCRO #BloodCancerResearch #DrugDevelopment #PrecisionOncology #ClinicalTrialSolutions

1

📊 Navigating the Biopharma Job Market in 2024: Key Insights, Trends, and Strategies 📈 Both job seekers and employers are navigating significant changes. Here’s a deep dive into the current trends shaping our industry, along with practical strategies to help you succeed in today’s competitive job market: 🔍 Hiring & Salary Trends High Demand for Specialized Expertise: With advances in immunotherapy, CRISPR gene editing, and personalized medicine, there’s a rising demand for specialized professionals. Roles in bioinformatics, clinical research, and data analytics are particularly sought after. Remote Work is Here to Stay: Many companies have embraced hybrid work models post-pandemic. Professionals now have the flexibility to contribute effectively from anywhere. Rising Salary Benchmarks: To attract top talent, salaries are climbing. Recent studies indicate a 10-15% increase in compensation for mid-to-senior roles in biopharma. 🛑 Challenges for Job Seekers & Employers Talent Shortages: Despite numerous job openings, there’s a notable shortage of candidates for highly specialized roles. Upskilling and continuous development are crucial to filling this gap. Keeping Pace with Rapid Innovation: Both employers and employees need to stay up-to-date with fast-moving technological advancements—a challenge, but also an exciting growth opportunity! Changing Hiring Processes: Companies are increasingly leveraging AI tools like applicant tracking systems (ATS) and automated video interviews to streamline hiring. While these tools improve efficiency, they can also make the process feel impersonal. 🌟 Personal Insights & Strategies From my experience helping candidates 🚀, here are a few strategies to help you thrive: Embrace Lifelong Learning: Stay relevant by enrolling in online courses, attending conferences, and actively networking within professional communities. Sharpen Your Digital Skills: Familiarize yourself with AI and machine learning applications in biopharma. Platforms like LinkedIn Learning and Coursera are great resources to stay ahead of digital trends. Leverage Technology for Job Search: Use AI tools like ChatGPT to refine your resume or practice for interviews. Tools like Clay can help you organize and streamline your job search across multiple platforms. Don’t Forget the Human Touch: In an age of automation, human connection is more important than ever. Personalize your job applications and engage directly with connections on LinkedIn or through email introductions. 💬 Let’s Connect! What trends have you noticed in the biopharma job market? How are you tackling these challenges? Drop a comment below—I’d love to hear your insights and experiences! By staying proactive and embracing the latest trends 📚🔧🔬, we can not only remain relevant but continue to thrive in this exciting industry. 🌍💡🏆 #Biopharma #JobMarket2024 #CareerGrowth #ContinuousLearning #AIinBiopharma

7

4 Comments